Tadalafil/Tamsulosin

他达拉非/坦洛新

Report date: 2026/02/04 16:35:08

Base Information

Drug NameTadalafil/Tamsulosin
Drug Alias NameTadalafil and Tamsulosin坦洛新他达拉非他达拉非坦洛新Tamsulosin and TadalafilTamsulosin/Tadalafil +[8] 
ClassificationSmall molecules
Mechanisms of ActionAlpha-1a adrenergic receptor antagonistsPhosphodiesterase 5A inhibitors
TargetsAlpha-1a adrenergic receptorPhosphodiesterase 5A
Therapy Area/IndicationsErectile DysfunctionProstatic Hyperplasia
Global Approved IndicationsErectile DysfunctionProstatic Hyperplasia
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2016/10/20
Country/TerritorySouth Korea
CombinationsYes Tamsulosin HydrochlorideTadalafil
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesYungjin Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesChong Kun Dang Pharmaceutical Corp
Active IndicationsErectile DysfunctionProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A